Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease

Mi Li, Alla Gustchina, Krisztina Matúz, J. Tőzsér, Sirilak Namwong, Nathan E. Goldfarb, Ben M. Dunn, Alexander Wlodawer

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Interactions between the protease (PR) encoded by the xenotropic murine leukemia virus-related virus and a number of potential inhibitors have been investigated by biochemical and structural techniques. It was observed that several inhibitors used clinically against HIV PR exhibit nanomolar or even subnanomolar values of K i, depending on the exact experimental conditions. Both TL-3, a universal inhibitor of retroviral PRs, and some inhibitors originally shown to inhibit plasmepsins were also quite potent, whereas inhibition by pepstatin A was considerably weaker. Crystal structures of the complexes of xenotropic murine leukemia virus-related virus PR with TL-3, amprenavir and pepstatin A were solved at high resolution and compared with the structures of complexes of these inhibitors with other retropepsins. Whereas TL-3 and amprenavir bound in a predictable manner, spanning the substrate-binding site of the enzyme, two molecules of pepstatin A bound simultaneously in an unprecedented manner, leaving the catalytic water molecule in place. Structured digital abstract and by () Interactions between the protease (PR) encoded by the xenotropic murine leukemia virus-related virus (XMRV) and a number of potential inhibitors have been investigated by biochemical and structural techniques. Binding data were obtained for a number of compounds and crystal structures of the complexes of XMRV PR with TL-3, amprenavir, and pepstatin A were solved at high resolution

Original languageEnglish
Pages (from-to)4413-4424
Number of pages12
JournalFEBS Journal
Volume278
Issue number22
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Xenotropic murine leukemia virus-related virus
Viruses
Peptide Hydrolases
HIV Protease
Crystal structure
Binding Sites
Molecules
pepstatin
Water
Enzymes
amprenavir

Keywords

  • aspartic protease
  • enzyme inhibition
  • inhibitor binding
  • retrovirus

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease. / Li, Mi; Gustchina, Alla; Matúz, Krisztina; Tőzsér, J.; Namwong, Sirilak; Goldfarb, Nathan E.; Dunn, Ben M.; Wlodawer, Alexander.

In: FEBS Journal, Vol. 278, No. 22, 11.2011, p. 4413-4424.

Research output: Contribution to journalArticle

Li, Mi ; Gustchina, Alla ; Matúz, Krisztina ; Tőzsér, J. ; Namwong, Sirilak ; Goldfarb, Nathan E. ; Dunn, Ben M. ; Wlodawer, Alexander. / Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease. In: FEBS Journal. 2011 ; Vol. 278, No. 22. pp. 4413-4424.
@article{3e1ce0f6fc9a4ef19a16a62329166ac7,
title = "Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease",
abstract = "Interactions between the protease (PR) encoded by the xenotropic murine leukemia virus-related virus and a number of potential inhibitors have been investigated by biochemical and structural techniques. It was observed that several inhibitors used clinically against HIV PR exhibit nanomolar or even subnanomolar values of K i, depending on the exact experimental conditions. Both TL-3, a universal inhibitor of retroviral PRs, and some inhibitors originally shown to inhibit plasmepsins were also quite potent, whereas inhibition by pepstatin A was considerably weaker. Crystal structures of the complexes of xenotropic murine leukemia virus-related virus PR with TL-3, amprenavir and pepstatin A were solved at high resolution and compared with the structures of complexes of these inhibitors with other retropepsins. Whereas TL-3 and amprenavir bound in a predictable manner, spanning the substrate-binding site of the enzyme, two molecules of pepstatin A bound simultaneously in an unprecedented manner, leaving the catalytic water molecule in place. Structured digital abstract and by () Interactions between the protease (PR) encoded by the xenotropic murine leukemia virus-related virus (XMRV) and a number of potential inhibitors have been investigated by biochemical and structural techniques. Binding data were obtained for a number of compounds and crystal structures of the complexes of XMRV PR with TL-3, amprenavir, and pepstatin A were solved at high resolution",
keywords = "aspartic protease, enzyme inhibition, inhibitor binding, retrovirus",
author = "Mi Li and Alla Gustchina and Krisztina Mat{\'u}z and J. Tőzs{\'e}r and Sirilak Namwong and Goldfarb, {Nathan E.} and Dunn, {Ben M.} and Alexander Wlodawer",
year = "2011",
month = "11",
doi = "10.1111/j.1742-4658.2011.08364.x",
language = "English",
volume = "278",
pages = "4413--4424",
journal = "FEBS Journal",
issn = "1742-464X",
publisher = "Wiley-Blackwell",
number = "22",

}

TY - JOUR

T1 - Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease

AU - Li, Mi

AU - Gustchina, Alla

AU - Matúz, Krisztina

AU - Tőzsér, J.

AU - Namwong, Sirilak

AU - Goldfarb, Nathan E.

AU - Dunn, Ben M.

AU - Wlodawer, Alexander

PY - 2011/11

Y1 - 2011/11

N2 - Interactions between the protease (PR) encoded by the xenotropic murine leukemia virus-related virus and a number of potential inhibitors have been investigated by biochemical and structural techniques. It was observed that several inhibitors used clinically against HIV PR exhibit nanomolar or even subnanomolar values of K i, depending on the exact experimental conditions. Both TL-3, a universal inhibitor of retroviral PRs, and some inhibitors originally shown to inhibit plasmepsins were also quite potent, whereas inhibition by pepstatin A was considerably weaker. Crystal structures of the complexes of xenotropic murine leukemia virus-related virus PR with TL-3, amprenavir and pepstatin A were solved at high resolution and compared with the structures of complexes of these inhibitors with other retropepsins. Whereas TL-3 and amprenavir bound in a predictable manner, spanning the substrate-binding site of the enzyme, two molecules of pepstatin A bound simultaneously in an unprecedented manner, leaving the catalytic water molecule in place. Structured digital abstract and by () Interactions between the protease (PR) encoded by the xenotropic murine leukemia virus-related virus (XMRV) and a number of potential inhibitors have been investigated by biochemical and structural techniques. Binding data were obtained for a number of compounds and crystal structures of the complexes of XMRV PR with TL-3, amprenavir, and pepstatin A were solved at high resolution

AB - Interactions between the protease (PR) encoded by the xenotropic murine leukemia virus-related virus and a number of potential inhibitors have been investigated by biochemical and structural techniques. It was observed that several inhibitors used clinically against HIV PR exhibit nanomolar or even subnanomolar values of K i, depending on the exact experimental conditions. Both TL-3, a universal inhibitor of retroviral PRs, and some inhibitors originally shown to inhibit plasmepsins were also quite potent, whereas inhibition by pepstatin A was considerably weaker. Crystal structures of the complexes of xenotropic murine leukemia virus-related virus PR with TL-3, amprenavir and pepstatin A were solved at high resolution and compared with the structures of complexes of these inhibitors with other retropepsins. Whereas TL-3 and amprenavir bound in a predictable manner, spanning the substrate-binding site of the enzyme, two molecules of pepstatin A bound simultaneously in an unprecedented manner, leaving the catalytic water molecule in place. Structured digital abstract and by () Interactions between the protease (PR) encoded by the xenotropic murine leukemia virus-related virus (XMRV) and a number of potential inhibitors have been investigated by biochemical and structural techniques. Binding data were obtained for a number of compounds and crystal structures of the complexes of XMRV PR with TL-3, amprenavir, and pepstatin A were solved at high resolution

KW - aspartic protease

KW - enzyme inhibition

KW - inhibitor binding

KW - retrovirus

UR - http://www.scopus.com/inward/record.url?scp=80255138061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80255138061&partnerID=8YFLogxK

U2 - 10.1111/j.1742-4658.2011.08364.x

DO - 10.1111/j.1742-4658.2011.08364.x

M3 - Article

C2 - 21951660

AN - SCOPUS:80255138061

VL - 278

SP - 4413

EP - 4424

JO - FEBS Journal

JF - FEBS Journal

SN - 1742-464X

IS - 22

ER -